StockNews.com began coverage on shares of Veradigm (NASDAQ:MDRX – Free Report) in a research note published on Monday. The firm issued a hold rating on the software maker’s stock.
Veradigm Stock Down 1.7 %
Shares of MDRX stock opened at $10.40 on Monday. Veradigm has a fifty-two week low of $5.01 and a fifty-two week high of $12.66. The stock’s 50-day moving average is $9.77 and its two-hundred day moving average is $9.51.
Hedge Funds Weigh In On Veradigm
A hedge fund recently bought a new stake in Veradigm stock. Innealta Capital LLC bought a new stake in Veradigm Inc. (NASDAQ:MDRX – Free Report) during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm bought 3,974 shares of the software maker’s stock, valued at approximately $38,000.
About Veradigm
Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.
Recommended Stories
- Five stocks we like better than Veradigm
- 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion
- Eli Lilly, Pfizer, and AstraZeneca: 2025 Vaccine Makers to Watch
- Trading Stocks: RSI and Why it’s Useful
- DICK’S Sporting Goods: The Under-the-Radar Buy-and-Hold Winner
- What Do S&P 500 Stocks Tell Investors About the Market?
- 2 Cheap Quantum Computing Stocks to Buy Instead of Chasing IonQ
Receive News & Ratings for Veradigm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veradigm and related companies with MarketBeat.com's FREE daily email newsletter.
